A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer Meeting Abstract
| Authors: | Goss, P. E.; Ingle, J. N.; Pritchard, K. I.; Robert, N. J.; Muss, H.; Gralow, J.; Gelmon, K. A.; Whelan, T. J.; Strasser-Weippl, K.; Rubin, S.; Sturtz, K.; Wolff, A. C.; Winer, E. P.; Hudis, C. A.; Stopeck, A.; Beck, J. T.; Kaur, J. S.; Whelan, K.; Tu, D.; Parulekar, W. R. |
| Abstract Title: | A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-06-20 |
| Start Page: | 745s |
| Language: | English |
| ACCESSION: | WOS:000443264100002 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2016.34.18_suppl.LBA1 |
| Notes: | Meeting Abstract: LBA1 -- Source: Wos |
